News
ARSP 2024 Annual Report Data Summary is now available for download
The Antimicrobial Resistance Surveillance Program (ARSP) presents national estimates and trends on the antimicrobial resistance of clinically significant aerobic…
Application for ARSP Accreditation 2025 Cycle is now open from June 02, 2025 – August 29, 2025
The ARSP Accreditation is granted to aerobic bacteriology laboratories that maintains suitable performance standards. The bacteriology laboratory applying for…
Revised Citizen’s Charter and Affidavit of Undertaking for ARSP Accreditation (June 2 – August 29, 2025)
Requirements and procedure for application to the Antimicrobial Resistance Surveillance Program (ARSP) Accreditation of aerobic bacteriology laboratories. Click “Download”…
ARSP 2023 Annual Report Data Summary is now available for download
The Antimicrobial Resistance Surveillance Program (ARSP) provides information on the national estimates and trends of antimicrobial resistance of aerobic…
DOH, RITM highlight importance of surveillance systems to understand the burden of antimicrobial resistance
Speakers and moderators of the NDF with AMU-PPS Lead Investigator Dr. Mari Rose De los Reyes (center) and AMU-PPS…
Latest Publication
Detection of a Serratia sarumanii outbreak in neonatal intensive care units using SaTScan and whole genome sequencing, Philippines, 2022
This study aimed to demonstrate the benefits of using SaTScan (Boston, MA, USA), a cluster-detection software programme, and whole…
High in vitro activity of the novel antimicrobial gepotidacin against Neisseria gonorrhoeae isolates in eight WHO – EGASP countries in three WHO regions, 2021–24
The ARSP EGASP Study Group contributed to a new multi-country WHO EGASP analysis evaluating gepotidacin, a first-in-class oral antimicrobial…
High susceptibility to the novel antimicrobial zoliflodacin among Neisseria gonorrhoeae isolates in eight WHO Enhanced Gonococcal Antimicrobial Surveillance Programme countries in three WHO regions, 2021-2024
The ARSP EGASP Study Group contributed to a recent multi-country study evaluating zoliflodacin, a new drug candidate for gonorrhea….
Ciprofloxacin resistance in Klebsiella pneumoniae: phenotype prediction from genotype and global distribution of resistance determinants
The Antimicrobial Resistance Surveillance Reference Laboratory (ARSRL) researchers joined the international KlebNET-GSP consortium in a new preprint that develops…
Antimicrobial resistance in Neisseria gonorrhoeae in nine sentinel countries within the World Health Organization Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP), 2023: a retrospective observational study
The Research Institute for Tropical Medicine (RITM) plays a key role in the Philippines’ participation in the WHO’s…
AFFILIATES
Announcements
Diversity, functional classification and genotyping of SHV β-lactamases in Klebsiella pneumoniae
Abstract Interpreting the phenotypes of blaSHV alleles in Klebsiella pneumoniae genomes is complex. Whilst all strains are expected to…
ARSP 2022 Annual Report Data Summary is now available for download
For 35 years, the Antimicrobial Resistance Surveillance Program (ARSP) provided information on the national estimates and trends of antimicrobial…
ARSP will be accepting applicants for ARSP Accreditation 2023-2024 cycle from June 15 – August 31, 2023
The ARSP Accreditation is granted to aerobic bacteriology laboratories that maintains suitable performance standards. The laboratory applying for ARSP…
ARSRL IS NOW ACCEPTING APPLICANTS FOR THE ONLINE WHONET TRAINING
The First Online WHONET Training will run from December 05 -11, 2022. It is a self-paced course uploaded in…